Is PTC Therapeutics, Inc. (PTCT) a Buy, Sell, or Hold?
NASDAQ : PTCT
PTC Therapeutics, Inc. — Analyst Ratings
$75.8 USD
-$1.02 (-1.33%)
- Volume
- 1.76M
- Average Volume
- 1.83M
- Market Capitalization
- $6.29B
- P/E Ratio
- -32.48
- Dividend Yield
- 0.00%
- Price Target
- $94.00
- Year High
- $90.87
- Year Low
- $43.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.44
Analyst Consensus Summary
Consensus Rating
Sell
26 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-19.4%
vs Current Price
Price Target
$94.00
Average TargetPrice Target Range
Lowest Target
$85.00
-10.8% DOWNSIDE
Average Target
$94.00
Median Estimate
Highest Target
$130.00
-41.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 26
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 17 | 7 | 2 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Judah Frommer | $94 | $75.355 | 2026-05-08 09:24 AM | 24.7% |
| Raymond James | Tiago Fauth | $108 | $69.11 | 2026-04-10 05:35 AM | 56.3% |
| Barclays | Eliana Merle | $120 | $70.66 | 2026-02-23 05:48 AM | 69.8% |
| RBC Capital | Brian Abrahams | $82 | $67.945 | 2026-02-20 08:05 AM | 20.7% |